AzTrials
AzTrials

Class II Division 1 MalocclusionNCT04905004

Efficiency of Canine Retraction Using Different Reactivation Intervals

A study testing Canine retraction in people with Class II Division 1 Malocclusion and Class III Malocclusion, run by Future University in Egypt at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Canine retraction after 1st premolar extracion into the extraction space is a routine treatment in orthodontics. Orthodontic patients requiring first premolar extraction, canine retraction and maximum anchorage were recruited for this randomized controlled trial. Read more about this study

Who is it for?
Ages 13 to 30 yearsHealthy volunteers can take part
What is being tested?
Canine retraction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteEgypt
Study dates
1 Apr 2017to 1 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patients requiring 1st premolar extraction (e.g bimaxillary dentoalveolar protrusion)
  • Erupted full set of permanent teeth (excluding 3rd molars)

Who cannot join

  • Systemic diseases that would interfere with bone metabolism
  • Craniofacial syndromes
  • congenitally missing or extracted permanent teeth.
  • periodontally compromised patients
  • smokers
  • pregnant women
  • previous orthodontic treatment

Trial locations and contacts

1 site in 1 country.

Reem ElShazly, MSc contact

+201114666516

reemhazem24@gmail.com

Rudayna El-Badawy, MSc contact

+201159218899

rudaynaelbadawy@gmail.com

Egypt1 site, 1 recruiting
  • Future University in Egypt

    Cairo, 11865

    Yehya Mostafa, PhD, yehya3d@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Comparing Canine Retraction Using Two-week, Four-week, Six-week and Eight-week Reactivation Intervals

Canine retraction after 1st premolar extracion into the extraction space is a routine treatment in orthodontics. Orthodontic patients requiring first premolar extraction, canine retraction and maximum anchorage were recruited for this randomized controlled trial. A search of the literature did not indicate the ideal frequency of elastomeric chain reactivation for optimum canine retraction. The study was approved by the ethical committee. The first premolars were extracted. Elastomeric chains were used to retract the canine distally into the 1st premolar space. The optimum reactivation interval was evaluated regarding the efficiency of treatment in terms of rate of canine retraction, canine tipping and rotation, root resorption and pain at the intervals of 2, 4, 6 and 8 weeks. Three dimensional imaging, as well as digital scanning were the methods for data collection.

Read the detailed description

The canines, 2nd premolars, 1st molars and 2nd molars were bonded and banded. Leveling and alignment was achieved. After the first premolar extraction, temporary anchorage devices were inserted interradicular between 2nd premolar and 1st molar. Canine retraction was performed on a 0.016" X 0.022" stainless steel arch wire. A power arm was extended to apply the force closer to the center of resistance and achieve bodily movement. Elastomeric chains were calibrated to deliver a force of 150g and extended from the power arm to the mini screws directly. Recruited patients were randomly allocated to four groups according to the duration between the elastomeric chain reactivation. Canine reactivation intervals were 2, 4, 6, or 8 weeks. Cone beam computed tomography was performed before canine retraction and after 6 months of retraction. Digital dental casts were taken before canine retraction and monthly for 6 months.

Being tested
Canine retraction
Medical subject headings
Malocclusion, Angle Class II, Malocclusion, Angle Class III, Malocclusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Canine retractionProcedure or surgery

    Canines will be retracted using short elastomeric chains. Force applied to canines will be 150g.

Study groups in NCT04905004
Study groupRoleWhat they receive
2-week reactivation intervalExperimentalReplacement of elastomeric chain every 2 weeks and reestablishing a 150 g force
Receives: Procedure: Canine retraction
4-week reactivation intervalActive comparatorReplacement of elastomeric chain every 4 weeks and reestablishing a 150 g force
Receives: Procedure: Canine retraction
6-week reactivation intervalExperimentalReplacement of elastomeric chain every 6 weeks and reestablishing a 150 g force
Receives: Procedure: Canine retraction
8-week reactivation intervalExperimentalReplacement of elastomeric chain every 8 weeks and reestablishing a 150 g force
Receives: Procedure: Canine retraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of canine retraction

    The distance measured between the canine cusp tips for each two consecutive digital models superimposed on the right and left medial palatal rugae.

    Measured: Baseline to 1 month

  2. Rate of canine retraction

    The distance measured between the canine cusp tips for each two consecutive digital models superimposed on the right and left medial palatal rugae.

    Measured: 1month to 2 months

  3. Rate of canine retraction

    The distance measured between the canine cusp tips for each two consecutive digital models superimposed on the right and left medial palatal rugae.

    Measured: 2 months to 3 months

  4. Rate of canine retraction

    The distance measured between the canine cusp tips for each two consecutive digital models superimposed on the right and left medial palatal rugae.

    Measured: 3 months to 4 months

  5. Rate of canine retraction

    The distance measured between the canine cusp tips for each two consecutive digital models superimposed on the right and left medial palatal rugae.

    Measured: 4 months to 5 months

  6. Rate of canine retraction

    The distance measured between the canine cusp tips for each two consecutive digital models superimposed on the right and left medial palatal rugae.

    Measured: 5 months to 6 months.

Secondary outcomes (15)
  1. Amount of canine retraction

    The change in distance measured from the canine cusp tip to the frontal plane, in millimeters; measured on CBCT

    Measured: Baseline to 6 months

  2. Canine tipping

    CBCT images at T0 and T1 were analyzed using Invivo 5 software. linear measurements were made from the long axis of the canines (cusp tip to root apex) to FP1 and FP2 for the upper and lower canines, respectively.

    Measured: Baseline to 6 months

  3. Canine rotation

    The change in the angle between a line connecting the maximum mesial and distal crown convexities and FP1 and FP2, for the upper and lower canines, respectively; measured on CBCT

    Measured: Baseline to 6 months

  4. Canine root resorption

    The change in the canine length, in millimeters, measured from cusp tip to root apex; measured on CBCT

    Measured: Baseline to 6 months

  5. First molar anchorage loss

    The change in distance measured from the mesio-buccal cusp tip of the first molar to the frontal plane, in millimeters; measured on CBCT

    Measured: Baseline to 6 months

  6. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: baseline to day 1

  7. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 2

  8. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 3

  9. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 4

  10. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 5

  11. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 6

  12. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 7

  13. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 8

  14. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 9

  15. Pain score

    The patient makes a mark along the Visual Analogue Scale (VAS) scale denoting the severity of pain: 0-100 0= no pain and 100= worst pain imaginable

    Measured: Baseline to day 10.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2021
  2. Study start1 Apr 2017
  3. Primary completion1 Jun 2022 (estimated)
  4. Study completion1 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04905004
Sponsor's protocol ID
20153110-8-14-2017
Status last verified
May 2021
First submitted
23 May 2021
Last updated
27 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Canine retraction in people with Class II Division 1 Malocclusion and Class III Malocclusion, run by Future University in Egypt at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Reem ElShazly, MSc (+201114666516, reemhazem24@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of canine retraction (time frame: Baseline to 1 month). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2021; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in